Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2009-01-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Health in this project is defined as the possibility of a subject to change and adapt easily in response to a certain challenge. Healthy subjects show resilience in different physiological processes related to oxidative stress, metabolic stress, neurological stress and inflammatory stress. The reaction/response to a challenge might be changed when subjects have consumed more or less vegetables and have an improved health status. The response might also differentiate between subjects differing in BMI (healthy weight versus overweight/obese). Supplementation of vegetables will be provided in two conditions: a low and a high daily intake (50 versus 200 grams daily). An intervention known to have positive effects on health is weight loss. This will be studied in relation to health (the reaction to the challenge test) as well.
A beneficial effect is present when 5% improvement of health markers is shown with vegetable supplementation, similar as is known from weight loss studies.
Objective: The primary objective of the present study is to set-up a methodology to investigate health based on the resilience to challenge. A secondary objective is the effectiveness of the challenge concept with a food intervention. The vegetable supplementation study is a first example to test the challenge concept. Therefore, vegetable consumption according to the recommendations of the Dutch Health Council of 200 grams of vegetables daily will be studied with an exercise challenge test, to investigate the beneficial 'health' effects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Fatty Acid Composition on Energy Intake and Satiety
NCT00242021
Effect of Fruit and Vegetable Intake on Markers of Fruit and Vegetable Consumption
NCT01591057
Effect of Fruit and Vegetables on Insulin Resistance
NCT00874341
Sustained Effect of Food Texture of Ultra-processed Foods on Energy Intake
NCT05561426
The Effect of Meal Texture on Intake
NCT05615350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study population: The number of subjects participating in the study will be 32, healthy, lean and obese men, aged between 18-45 years.
Intervention: each intervention lasts four weeks:
* High Vegetable treatment: consumption of 200 grams of vegetables daily;
* Low Vegetable treatment: consumption of 50 grams of vegetables daily;
* An energy restricted diet intervention with the habitual vegetable consumption.
Main study parameters/endpoints: A 'challenge test' will be used as a physical stress test to examine whether subjects show more or less resilience to the test. The reaction and recovery of the human system to the exercise test may be used as indicators of health status on different biological analyses (transcriptomics; metabolomics; rules based medicine pm). Different analyses to measure oxidative stress will be performed. Also standard health biomarkers will be determined to examine the intervention effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High vegetable dose
Consumption of 200 grams of vegetables daily, for four weeks.
Vegetables
200 or 50 grams of vegetables daily for four weeks
Low vegetable dose
Consumption of 50 grams of vegetables daily, for four weeks.
Vegetables
200 or 50 grams of vegetables daily for four weeks
Weight loss interventio
Consumption of - 1000 kcal daily, for four weeks to be used as a positive control for the vegetables interventions.
energy restriction
Consume about 1000 kcal less daily, for four weeks, as a positive control to the vegetables interventions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vegetables
200 or 50 grams of vegetables daily for four weeks
energy restriction
Consume about 1000 kcal less daily, for four weeks, as a positive control to the vegetables interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* health and lifestyle questionnaire, (P8374 F02; in Dutch)
* physical examination
* results of the pre-study laboratory tests
2. Males aged between 18 and 45 years at Day 01 of the study
3. Body Mass Index (BMI): for the lean : between 20 and 25 kg/m2; obese between 30 and 35 kg/m2
4. Normal Dutch eating habits as assessed by P8374 F02
5. Used to consume vegetables daily and liking vegetables (P8374 F02 and F06)
6. Physically able to perform a maximal cycling exercise test
7. Voluntary participation
8. Having given written informed consent
9. Willing to comply with the study procedures
10. Appropriate veins for blood sampling according to TNO
11. Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years
12. Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned.
Exclusion Criteria
2. Participation in any non-invasive clinical trial up to 30 days before Day 01 of this study, including no blood sampling and/or oral, intravenous, or inhalatory administration of substances
3. Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease or hypertension and/or (food) allergy
4. Using prescribed medication or taking pain killers on a regular basis (judged by the medical investigator) ;
5. Smoking
6. Exercise regularly and exceed the Dutch Standard of Healthy Physical Activity of 2.5 hours/week
7. Alcohol consumption \> 28 units/week
8. Reported unexplained weight loss or gain of \> 2 kg in the month prior to the pre-study screening
9. Reported slimming or medically prescribed diet
10. Recent blood donation (\<1 month prior to the start of the study)
11. Not willing to give up blood donation during the study
12. Personnel of TNO Quality of Life, their partner and their first and second degree relatives
13. Not having a general practitioner
14. Not willing to accept information-transfer concerning participation in the study, or information regarding his health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner.
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Netherlands: Ministry of Health, Welfare and Sports
OTHER_GOV
TNO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
W.J. Pasman
TNO, Zeist, The Netherlands
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilrike Pasman, PhD
Role: PRINCIPAL_INVESTIGATOR
TNO
Ineke Klöpping-Ketelaars, PhD, MD
Role: STUDY_DIRECTOR
TNO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TNO Quality of Life, Metabolic ward
Zeist, Utrecht, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schoen ED, Rubingh CM, Wopereis S, van Erk M. Controlling false discovery rates in factorial experiments with between-subjects and within-subjects tests. BMC Res Notes. 2013 May 21;6:204. doi: 10.1186/1756-0500-6-204.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P8374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.